Dr. Arjab Adhikari, MD

Dr. Adhikari practices at Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health.

Dr. Adhikari's NPI, 1689288904, was assigned on September 3, 2020. Dr. Adhikari holds Missouri license 2023050747.

Dr. Adhikari's primary practice is Barnes-Jewish Hospital, at One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110 in St. Louis City. The practice phone is (314) 747-3000. Dr. Adhikari also practices at Barnes-Jewish Hospital, 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110.

Dr. Adhikari's primary practice is Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health. The medical group on file is WashU Medicine Psychiatry.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Adhikari practices. Vendor and product names are available with a free account.

Hospitalist is Dr. Adhikari's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Adhikari is licensed in Missouri.

CMS data shows 159 Medicare services from Dr. Adhikari across 2 procedure codes in 2024, for 44 Medicare patients. Medicare paid $11,739 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 44 Medicare patients who saw Dr. Adhikari in 2024. The largest group is 65 to 74, with 20 patients. 75% of them have high blood pressure, and 73% have high cholesterol. Their average risk score is 3.40, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Adhikari's median patient age at 68, with 44% women.

In 2024, Dr. Adhikari wrote 64 Medicare Part D claims for 19 patients. 89% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $74 in total drug cost.

Dr. Adhikari accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Adhikari, published from 2022 to 2024. 2022 was the busiest year, with 2. The most frequent topics are Immune Checkpoint Inhibitors. Dr. Adhikari has published most often in Cancer Epidemiol. Dr. Adhikari's most frequent co-authors are Drashti Niteshkumar Antala, Utsuk Bhattarai, MD and Elaine Eunnae Cha.

CMS Open Payments shows 2 general payments to Dr. Adhikari from 2 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Medtronic, Inc. paid the most, $131.